EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Significantly Higher Glucose Concentration in Plasma Collected with Glycolytic Inhibitors than in Serum: Impact of Insulin Resistance

Akihiro Yoshida iD, Takumi Nagasawa iD, Madoka Inoue, Suguru Hiramoto, Fumitaka Murakami, Mari Hashimoto, Sakura Motoki, Mayumi Nishiyama, Katsuhiko Tsunekawa iD, Takao Kimura iD

Nutrients · 2026

DOI: 10.3390/nu18050813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Akihiro Yoshida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Showa-Machi 3-39-22, Maebashi 371-8511, Gunma, Japan. Hauptthemen laut MEDLINE: Blood Glucose, Insulin Resistance, Glycolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: scientific research from the Ministry of Education, Culture, Sports Science, and Technology of Japan, Ministry of Education, Culture, Sports Science, and Technology of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to identify factors influencing the magnitude of the difference between plasma glucose concentration (Glu(P)) and serum glucose concentration (Glu(S)).

Methods

A total of 333 healthy Japanese adults aged 22–29 years (212 males and 121 females) were enrolled. Plasma samples were collected using glycolytic inhibitors, whereas serum samples were obtained without glycolytic inhibitors and kept at room temperature. Glu(P) and Glu(S) were measured and compared.

Results

The median difference between Glu(P) and Glu(S), defined as Glu(P-S), was 4 mg/dL across all participants, with no gender-related differences. A strong positive correlation was observed between Glu(P) and Glu(S). Glu(P-S) was positively correlated with body mass index, Glu(P), triglyceride–glucose index, white blood cell count, serum sodium, magnesium, and zinc levels. In contrast, Glu(P-S) was negatively correlated with Glu(S), hemoglobin A1c (HbA1c), homeostasis model assessment of beta-cell function, and high-density lipoprotein cholesterol (HDL-C). Multiple regression analysis demonstrated that HDL-C and HbA1c were independent determinants of Glu(P-S) in the overall cohort. Among females, HDL-C, triglyceride, low-density lipoprotein cholesterol, ferritin, and C-reactive protein independently influenced Glu(P-S), whereas no independent determinants were identified in males.

Conclusions

Plasma glucose concentrations measured with glycolytic inhibitors were significantly higher than serum glucose concentrations measured without inhibitors at room temperature. The magnitude of Glu(P-S) appears to be associated with markers of insulin resistance, particularly HDL-C levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseInsulin ResistanceGlycolysisHumansMaleFemaleAdultYoung AdultCholesterol, HDLGlycated HemoglobinTriglyceridesBody Mass IndexMagnesium

Stichwörter der Autor:innen

glucose concentrationglycolysishigh-density lipoprotein cholesterolinsulin resistanceplasmaserumsodium fluoride–citrate

Substanzen

Blood GlucoseCholesterol, HDLGlycated HemoglobinTriglyceridesMagnesium

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Showa-Machi 3-39-22, Maebashi 371-8511, Gunma, Japan.
  • Clinical Laboratory Center, Gunma University Hospital, Showa-Machi 3-39-22, Maebashi 371-8511, Gunma, Japan.
  • Department of Medical Education and Development, Gunma University Graduate School of Medicine, Showa-Machi 3-39-22, Maebashi 371-8511, Gunma, Japan.
  • Department of Integrated Health Science, Graduate School of Food and Population Health Science, Gunma University, Aramaki-Machi 4-2, Maebashi 371-8510, Gunma, Japan.
  • Ikuei University, Kyome-Machi 1656-1, Takasaki 370-0011, Gunma, Japan.
  • General Health Support Center, Gunma University, Aramaki-Machi 4-2, Maebashi 371-8510, Gunma, Japan.

ORCID-Profile: Akihiro Yoshida, Takumi Nagasawa, Katsuhiko Tsunekawa, Takao Kimura

Förderung

  • scientific research from the Ministry of Education, Culture, Sports Science, and Technology of Japan
  • Ministry of Education, Culture, Sports Science, and Technology of Japan

Zitieren

APA

Yoshida, A., Nagasawa, T., Inoue, M., Hiramoto, S., Murakami, F., Hashimoto, M., Motoki, S., Nishiyama, M., Tsunekawa, K., & Kimura, T. (2026). A Significantly Higher Glucose Concentration in Plasma Collected with Glycolytic Inhibitors than in Serum: Impact of Insulin Resistance. Nutrients. https://doi.org/10.3390/nu18050813

Vancouver

Yoshida A, Nagasawa T, Inoue M, Hiramoto S, Murakami F, Hashimoto M, et al. A Significantly Higher Glucose Concentration in Plasma Collected with Glycolytic Inhibitors than in Serum: Impact of Insulin Resistance. Nutrients. 2026. doi:10.3390/nu18050813

BibTeX
@article{Yoshida2026,
  author = {Yoshida, Akihiro and Nagasawa, Takumi and Inoue, Madoka and Hiramoto, Suguru and Murakami, Fumitaka and Hashimoto, Mari and Motoki, Sakura and Nishiyama, Mayumi and Tsunekawa, Katsuhiko and Kimura, Takao},
  title = {A Significantly Higher Glucose Concentration in Plasma Collected with Glycolytic Inhibitors than in Serum: Impact of Insulin Resistance},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18050813}
}
Kostenlos starten →